Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 7/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.46 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.46 |
| ▸ | DRD3 | P35462 | 3/20 | 0.46 |
| ▸ | CACNA1B | Q00975 | 3/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.46 |
| ▸ | HTR1A | P08908 | 2/20 | 0.46 |
| ▸ | DRD1 | P21728 | 2/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.46 |
| ▸ | THPO | P40225 | 2/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13057486 | 0.77 | SLC6A2 (0.46) | SLC6A4LMNASLC6A2SLC22A1CHRM2 | |
| SCHEMBL13485697 | 0.76 | CYP2D6 (0.53) | SLC6A4LMNASLC6A2SLC22A1CHRM2 | |
| SCHEMBL22186874 | 0.72 | SMPD1 (0.64) | LMNACYP2D6CYP3A4ALDH1A1SMPD1 | |
| SCHEMBL1102396 | 0.71 | L3MBTL1 (0.49) | SLC6A4LMNASLC6A2SLC22A1CHRM2 | |
| Hydrochloric Acid SCHEMBL4225623 | 0.71 | SLC6A4 (0.60) | SLC6A4LMNASLC6A2SLC22A1CHRM2 | |
| SCHEMBL20345836 | 0.70 | LMNA (0.41) | SLC6A4LMNASLC6A2SLC22A1CHRM2 | |
| SCHEMBL14567692 | 0.70 | POLB (0.46) | SLC6A4LMNASLC6A2SLC22A1CHRM2 | |
| SCHEMBL9149761 | 0.69 | TDP1 (0.47) | LMNADRD3CYP2D6CYP3A4NFKB1 | |
| SCHEMBL20349187 | 0.69 | SLC6A2 (0.42) | SLC6A4LMNASLC6A2SLC22A1CHRM2 | |
| SCHEMBL3531558 | 0.67 | HTR2A (0.55) | SLC6A4LMNASLC6A2SLC22A1CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100311727-A1 | THERAPEUTIC AMINE-ARYLSULFONAMIDE CONJUGATE COMPOUNDS | ALGEBRA, INC. (US) | 2010-12-09 | — | — | US | disclosed |
| US-7763612-B2 | Therapeutic amine-arylsulfonamide conjugate compounds | ALGEBRA, INC. (US) | 2010-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311727-A1 | THERAPEUTIC AMINE-ARYLSULFONAMIDE CONJUGATE COMPOUNDS | AADAT, AADAC, AANAT | SLC6A4 114/4885LMNA 4420/4885SLC6A2 49/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.